1Libby P, Ridker PM. Novel inflammatory markers of coronary risk ." theory versus practice[ J]. Circulation, 1999,100( 11 ) : 1148-1150.
2Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atheroscleretic lesions of human coronary arteries[ J]. Arterioscler Thremb Vasc Biol, 1998,18(9) : 1386-1392.
4Haverkate F, Thompson SG ,Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group[J]. Lancet, 1997,349(9050) :462-466.
5Sorelle R.Weight loss decreases C-reactive protein levels[J].Circulation.2002,105(5):E9071-9072.
6Liu S,Manson JE,Buring JE,et al.Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women[J].Am J Clin Nutr,2002,75(3):492-498.
7Sacks FM,Ridker PM.Lipid lowering and beyond:results from the CARE study on Lipoproteins and inflammation.Cholesterol and Recurrent Events[J].Herz,1999,24(1):51-56.
8Sattar N,Perera M,Small M,et al.Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes[J].Lancet 1999,354(9177):487-488.
9Bautista LE,Lopez-Jaramillo P,Vera LM,et al.Is C-reactive protein an independent risk factor for essential hypertension[J].J Hypertens,2001,19(5):857-861.
10Retterstol L,Eikval L,Bohn M,et al.C-reactive protein predicts death in patients with previous premature myocardial infarction-a 10 year follow-up study[J].Atherosclerosis,2002,160(2):433-440.
